FrancophonIA/ELRC3.0 huggingface dataset:
English: Foclivia suspension for injection in multidose container Pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
Danish: Foclivia injektionsvæske, suspension i flerdosisbeholder Pandemisk influenzavaccine (H5N1) (overfladeantigen, inaktiveret, adjuveret)
English: Study V87P13 21 days after 2nd dose N=128
Danish: Studie V87P13 21 dage efter 2. dosis N=128
English: Single dose vial: 1 vial containing a single dose (0.5 ml) for injection Instructions for administration of the vaccine:
Danish: Enkeltdosishætteglas: 1 hætteglas, der indeholder en enkelt dosis (0,5 ml) til injektion.
English: Study V87P1 21 days after 2nd dose N=149
Danish: Studie V87P1 21 dage efter 2. dosis N=149
English: 10 x 10 doses 1 dose (0.5 ml)
Danish: 10 x 10 doser
English: - Periodicity should be reviewed by the MAH and the (Co-)Rapporteur at 6 monthly intervals.
Danish: - Frekvensen tages op til overvejelse af indehaveren af markedsføringstilladelsen og (Co-)
English: Study V87P1 21 days after 2nd dose N=37
Danish: Studie V87P1 21 dage efter 2. dosis N=37
English: Study V87P13 21 days after 2nd dose N=210
Danish: Studie V87P13 21 dage efter 2. dosis N=210
English: Sodium chloride, potassium chloride, potassium dihydrogen phosphate, disodium phosphate dihydrate, magnesium chloride hexahydrate, calcium chloride dihydrate, thiomersal, water for injections.
Danish: Natriumchlorid, kaliumchlorid, kaliumdihydrogenphosphat, dinatriumphosphatdihydrat, magnesiumchloridhexahydrat, calciumchloriddihydrat, thiomersal, vand til injektioner.
English: Study V87P13 21 days after 2nd dose N=143
Danish: Studie V87P13 21 dage efter 2. dosis N=143
English: Study V87P13 21 days after 2nd dose N=207
Danish: Studie V87P13 21 dage efter 2. dosis N=207
English: - Convulsion:
Danish: - Convulsio:
English: Foclivia suspension for injection in multidose container Pandemic Influenza Vaccine (surface antigen, inactivated, adjuvanted)
Danish: Foclivia injektionsvæske, suspension i flerdosisbeholder Pandemisk influenzavaccine (overfladeantigener, inaktiveret, adjuveret)
English: Therefore, tell the doctor or nurse if you fainted with a previous injection.
Danish: Tal med lægen eller apoteket, hvis en bivirkning bliver værre, eller hvis du får bivirkninger, som ikke er nævnt her.
English: Foclivia suspension for injection in pre-filled syringe Pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)
Danish: Foclivia injektionsvæske, suspension i fyldt injektionssprøjte Pandemisk influenzavaccine (H5N1) (overfladeantigen, inaktiveret, adjuveret)
English: Foclivia suspension for injection in pre-filled syringe Pandemic Influenza Vaccine (surface antigen, inactivated, adjuvanted)
Danish: Foclivia injektionsvæske, suspension i fyldt injektionssprøjte Pandemisk influenzavaccine (overfladeantigen, inaktiveret, adjuveret)
English: Sodium chloride, potassium chloride, potassium dihydrogen phosphate, disodium phosphate dihydrate, magnesium chloride hexahydrate, calcium chloride dihydrate, water for injections.
Danish: Natriumchlorid, kaliumchlorid, kaliumdihydrogenphosphat, dinatriumphosphatdihydrat, magnesiumchloridhexahydrat, calciumchloriddihydrat, vand til injektioner.
English: Sodium chloride, Potassium chloride, Potassium dihydrogen phosphate, Disodium phosphate dihydrate, Magnesium chloride hexahydrate, Calcium chloride dihydrate, Thiomersal,
Danish: Kaliumdihydrogenphosphat Dinatriumphosphatdihydrat Magnesiumchloridhexahydrat Calciumchloriddihydrat Thiomersal
English: Sodium chloride, Potassium chloride, Potassium dihydrogen phosphate, Disodium phosphate dihydrate, Magnesium chloride hexahydrate, Calcium chloride dihydrate, Water for injections.
Danish: Kaliumdihydrogenphosphat, Dinatriumphosphatdihydrat, Magnesiumchloridhexahydrat, Calciumchloriddihydrat, Vand til injektionsvæsker.
English: Fever ≥ 38°C (≥ 40°C) Any Other Adverse Event Adolescents(9-<18 years)
Danish: Enhver anden uønsket hændelse 36 % Unge (9-<18 år)
English: Rare (may affect up to 1 in 1,000 people).
Danish: Ikke almindelig: (kan forekomme hos 1-10 ud af 1.000 vaccinerede).
English: Posology
Danish: Natriumcitrat
English: AstraZeneca Kft. 1113 Budapest, Bocskai út 134-146 Hungary
Danish: 1113 Budapest, Bocskai út 134-146 Ungarn
English: List of the names, pharmaceutical form, strengths of the medicinal products, route of administration, marketing authorisation holders in the Member States
Danish: FORTEGNELSE OVER LÆGEMIDLERNES NAVNE, LÆGEMIDDELFORM(ER), STYRKE(R), INDGIVELSESVEJ(E), INDEHAVER(E) AF MARKEDSFØRINGSTILLADELSE(R) I MEDLEMSSTATERNE
English: AstraZeneca AS Boks 200 Vinderen NO-0319 Oslo, Norway
Danish: AstraZeneca AS Boks 200 Vinderen NO-0319 Oslo, Norge
English: DK-2620 Albertslund, Denmark
Danish: DK-2620 Albertslund, Danmark
English: AstraZeneca GmbH 22876 Wedel, Germany
Danish: AstraZeneca GmbH 22876 Wedel, Tyskland
English: Almirall S.A., Ronda General Mitre, 151 08022 Barcelona, Spain
Danish: Ronda General Mitre, 151 08022 Barcelona, Spanien
English: Takeda UK Limited, Takeda House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, Buckinghamshire HP10 OHH United Kingdom.
Danish: Takeda UK Limited, Takeda House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, Buckinghamshire HP10 OHH
English: AstraZeneca SA Theotokopoulou 4 & Astronafton 151 25 Maroussi Greece
Danish: Grækenland AstraZeneca SA Theotokopoulou 4 & Astronafton 151 25 Maroussi
English: AstraZeneca Österreich GmbH., Schwarzenbergplatz 7, A-1037 Wien, Austria
Danish: AstraZeneca Österreich GmbH., Schwarzenbergplatz 7, A-1037 Wien, Østrig
English: AstraZeneca SpA Palazzo Volta-via F Sforza - 20080 Basiglio (MI)Italy
Danish: Palazzo Volta-via F Sforza - 20080 Basiglio (MI) - Italien
English: Takeda Italia Farmaceutici S.p.A., Via Elio Vittorini, 129 00144 Roma Italy
Danish: Takeda Italia Farmaceutici S.p.A., Via Elio Vittorini, 129
English: AstraZeneca 1, Place Renault 92844 RueilMalmaison Cedex France
Danish: 1, Place Renault 92844 Rueil-Malmaison Cedex Frankrig
English: Atacand Plus
Danish: Atacand Plus Mite
English: Takeda Pharma Ges.m.b.H., Seidengasse 33-35, 1070 Wien, Austria
Danish: Takeda Pharma Ges.m.b.H., Seidengasse 33-35, 1070 Wien,
English: Czech Republic AstraZeneca UK Ltd., Macclesfield, Cheshire, United Kingdom
Danish: AstraZeneca UK Ltd., Macclesfield, Cheshire,
English: 15 Stanhope Gate London W1K 1LN United Kingdom
Danish: AstraZeneca UK Limited 15 Stanhope Gate London W1K 1LN Storbritannien
English: Capability Green, Luton, LU1 3LU, United Kingdom
Danish: AstraZeneca UK Limited, 600 Capability Green, Luton, LU1 3LU, Storbritannien
English: Viktoriaallee 3-5, 52066 Aachen, Germany
Danish: Takeda Pharma GmbH, Viktoriaallee 3-5, 52066 Aachen, Tyskland
English: Laboratoires Takeda, 11-15, quai de Dion Bouton,
Danish: Laboratoires Takeda, 11-15, quai de Dion Bouton, 92816 Puteaux Cedex, Frankrig
English: AstraZeneca AB, Strängnäsvägen 44, S-151 85 Södertälje, Sweden
Danish: AstraZeneca AB, Strängnäsvägen 44, S-151 85 Södertälje, Sverige
English: Netherlands AstraZeneca BV Louis Pasteurlaan 5
Danish: AstraZeneca BV Louis Pasteurlaan 5 2719 EE Zoetermeer Holland
English: AstraZeneca AB 151 85 Södertälje, Sweden
Danish: AstraZeneca AB 151 85 Södertälje, Sverige
English: LusomedicamentaSociedade Técnica Farmacêutica, S.A. Estrada Consiglieri Pedroso, 69 BQueluz de Baixo 2730-055 Barcarena, Portugal
Danish: Lusomedicamenta - Sociedade Técnica Farmacêutica, S.A. Estrada Consiglieri Pedroso, 69 BQueluz de Baixo
English: AstraZeneca AB, S151 85 Södertälje, Sweden
Danish: AstraZeneca AB, S-151 85 Södertälje, Sverige
English: LusomedicamentaSociedade Técnica Farmacêutica, S.A., Estrada Consiglieri Pedroso, 69 BQueluz de Baixo 2730-055 Barcarena, Portugal
Danish: Lusomedicamenta - Sociedade Técnica Farmacêutica, S.A., Estrada Consiglieri Pedroso, 69 BQueluz de Baixo
English: 28033 Madrid, Spain
Danish: 2730-055 Barcarena, Portugal
English: United Kingdom.
Danish: Storbritannien
English: B-1180 Brussels
Danish: NV AstraZeneca SA Egide Van Ophemstraat 110 B-1180 Brussels Belgien
English: AstraZeneca UK Limited
Danish: AstraZeneca SpA
English: Ratacand Plus 32 mg / 12.5 mg
Danish: Atacand Plus 32 mg/12.5 mg
English: Atacand Zid 16mg / 12.5 mg
Danish: Atacand Zid 16mg / 12,5 mg 16 mg/12,5 mg Tablet
English: Atacand Plus 16/12.5 mg
Danish: Atacand Plus 16 mg/12.5 mg
English: 16mg/12,5mg comprimé
Danish: CoKenzen 16mg/12,5mg comprimé
English: Ratacand Plus 32 mg / 25 mg
Danish: Atacand Plus Forte 32 mg/25 mg
English: 32mg/25mg comprimidos
Danish: Parapres Plus Forte 32mg/25mg comprimidos
English: Blopress Plus 32mg/ 12,5mgTabletten
Danish: Blopress Plus 32mg/ 12,5mg - Tabletten
English: CoKenzen
Danish: AstraZeneca
English: Blopress Plus 16mg/12.5mgTabletten
Danish: Blopress Plus 16mg/12.5mg - Tabletten
English: The European Commission granted a marketing authorisation valid throughout the European Union for Hexyon on 17 April 2013.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Hexyon den 17. april 2013.
English: Hexyon is a vaccine.
Danish: Hexyon er en vaccine.
English: The full EPAR for Hexyon can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Hexyon findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This is a summary of the European public assessment report (EPAR) for Hexyon.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Hexyon.
English: Vaccination with Hexyon should be carried out according to official recommendations.
Danish: Vaccination med Hexyon bør foretages i henhold til officielle anbefalinger.
English: Other information about Hexyon
Danish: Andre oplysninger om Hexyon
English: What measures are being taken to ensure the safe and effective use of Hexyon?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Hexyon?
English: The two-dose vaccination schedule was investigated in an additional main study involving 554 children.
Danish: Vaccinationsplanen med to doser blev undersøgt i en yderligere hovedundersøgelse hos 554 børn.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Hexyon's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) konkluderede, at fordelene ved Hexyon opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: Why is Hexyon approved?
Danish: Hvorfor blev Hexyon godkendt?
English: Hexyon contains small amounts of materials derived from the bacteria and viruses it protects against.
Danish: Hexyon indeholder små mængder af materialer, der stammer fra bakterien og virusset, som det beskytter imod.
English: It is not intended to provide practical advice on how to use Hexyon.
Danish: Det er ikke en praktisk vejledning i, hvordan Hexyon bør anvendes.
English: What is Hexyon and what is it used for?
Danish: Hvad er Hexyon, og hvad anvendes det til?
English: Regarding safety, the CHMP considered that Hexyon's overall safety profile is similar to other vaccines, although vaccination with Hexyon is more likely than similar vaccines to cause reactions (mainly at the injection site).
Danish: Med hensyn til sikkerheden fandt CHMP, at Hexyons sikkerhedsprofil overordnet svarer til andre vacciners, omend der er større sandsynlighed for, at vaccination med Hexyon i forhold til lignende vacciner vil fremkalde reaktioner (hovedsagelig på injektionsstedet).
English: Hexyon has been studied in several countries worldwide in 12 main studies involving over 3,400 children between six weeks and two years of age who were given three doses of the vaccine during their first six months of life according to different local vaccination schedules.
Danish: Hexyon er blevet undersøgt i en række lande over hele verden i 12 hovedundersøgelser med over 3 400 børn mellem seks uger og to år gamle, der fik tre doser af vaccinen inden seksmåneders alderen i henhold til forskellige lokale vaccinationsplaner.
English: The effects were compared with a combination of separate vaccines designed to protect against the diseases included in Hexyon.
Danish: Virkningen blev sammenlignet med en kombination af separate vacciner mod de sygdomme, der dækkes af Hexyon.
English: What are the risks associated with Hexyon?
Danish: Hvilken risiko er der forbundet med Hexyon?
English: Hexyon is given by deep injection into a muscle, normally in the upper thigh or the shoulder.
Danish: Hexyon gives ved dyb indsprøjtning i en muskel, sædvanligvis i den øverste del af låret eller i skulderen.
English: For more information about treatment with Hexyon, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Hexyon, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: Hexyon must not be used in children who have ever had an allergic reaction to Hexyon or a vaccine containing the same components, including substances used during the manufacture of the vaccine and which may be found at extremely low levels (such as the antibiotics neomycin or streptomycin).
Danish: Hexyon må ikke anvendes til børn, som tidligere har haft en allergisk reaktion over for Hexyon eller en vaccine, der indeholder de samme komponenter, herunder stoffer, der anvendes ved fremstilling af vaccinen og som muligvis kan forefindes i ekstremt små mængder (som f.eks. antibiotikaene neomycin eller streptomycin).
English: These studies showed that Hexyon produces similar antibody profiles over time to comparable vaccines, and that the vaccine can be given at the same time as Prevenar and Rotarix.
Danish: Undersøgelserne viste, at Hexyon frembringer antistofdannelse med samme forløb over tid som andre tilsvarende vacciner, og at vaccinen kan gives samtidig med Prevenar og Rotarix.
English: The most common side effects with Hexyon include pain and redness at the site of injection, irritability and crying.
Danish: De hyppigste bivirkninger ved Hexyon er smerter og rødme på injektionsstedet, irritabilitet og grådreaktion.
English: The CHMP noted that Hexyon has been shown to produce protective antibody levels against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and H. influenzae type b infections in children between six weeks and two years of age regardless of ethnicity.
Danish: CHMP bemærkede, at Hexyon har vist sig at udvikle beskyttende antistofniveauer mod difteri, stivkrampe, kighoste, hepatitis B, poliomyelitis og H. influenzae type b-infektioner hos børn mellem seks uger og to år uanset etnisk oprindelse.
English: For practical information about using Hexyon, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Hexyon, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: Hexyon or an appropriate combination of other vaccines can be used for the booster dose.
Danish: Som boosterdosis kan anvendes Hexyon eller en passende kombination af andre vacciner.
English: How is Hexyon used?
Danish: Hvordan anvendes Hexyon?
English: It must not be used in children who have ever had encephalopathy (a brain disease) of unknown cause within seven days of receiving a vaccine containing pertussis components in the past.
Danish: Hexyon må ikke anvendes hos børn, der tidligere har fået encefalopati (en hjernesygdom) af ukendt årsag inden for syv dage efter at være blevet vaccineret med en vaccine indeholdende komponenter af kighoste (pertussis).
English: For the full list of all side effects reported with Hexyon, see the package leaflet.
Danish: Den fuldstændige liste over indberettede bivirkninger ved Hexyon fremgår af indlægssedlen.
English: In the study, children who either received Hexyon produced a similar antibody response to those who received a comparator vaccine (Infanrix hexa), when given as a two-dose schedule followed by a booster 6 months later.
Danish: I denne undersøgelse udløstes der hos de børn, der fik Hexyon, en antistofrespons, der svarede til antistofresponsen hos de børn, der fik en sammenligningsvaccine (Infanrix hexa), når vaccinen blev givet som en todosisplan efterfulgt af en boostervaccine seks måneder senere.
English: Hexyon is a vaccine containing active substances derived from diphtheria, tetanus, pertussis and Haemophilus influenzae type b bacteria, the hepatitis B virus, and inactivated polioviruses.
Danish: Hexyon er en vaccine, der indeholder aktive stoffer afledt af difteri-, stivkrampe-, kighoste- og Haemophilus influenzae type b-bakterier, hepatitis B-virus og inaktiverede poliovirusser.
English: What benefits of Hexyon have been shown in studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Hexyon?
English: Vaccination with Hexyon should be postponed if a child has a moderate to severe fever.
Danish: Hos børn med moderat til svær feber bør vaccination med Hexyon udsættes.
English: The studies showed that protective antibody levels against the various diseases developed in between 90 and 100% of children after the first three doses of Hexyon; protection was maintained or improved when a booster dose was given.
Danish: Undersøgelserne viste, at der hos mellem 90 % og 100 % af børnene blev dannet en beskyttende mængde antistoffer mod de forskellige sygdomme efter de første tre doser af Hexyon.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Hexyon have been included in the summary of product characteristics and the package leaflet.
Danish: I produktresuméet og indlægssedlen er der indføjet anbefalinger og forholdsregler, som sundhedspersonale og patienter skal følge med henblik på sikker og effektiv anvendelse af Hexyon.
English: How does Hexyon work?
Danish: Hvordan virker Hexyon?
English: Hexyon is available as a suspension for injection in vials and prefilled syringes.
Danish: Hexyon leveres som injektionsvæske (suspension) i hætteglas og fyldte sprøjter.
English: A subsequent study involving 455 children looked at the longer-term persistence of protective antibodies up to 3 years after a booster dose with Hexyon, and another study in 1,336 children evaluated the response to different lots of the vaccine and what happened when it was given with vaccines for infections caused by the bacterium Streptococcus pneumoniae (Prevenar) and rotavirus (Rotarix).
Danish: Endnu en undersøgelse med 1 336 børn vedrørte virkningen af forskellige vaccinebatcher (produktionsserier), og hvad der skete, når vaccinen blev givet sammen med vacciner mod bakterien Streptococcus pneumoniae (Prevenar) og rotavirus (Rotarix).
English: Treatment is continued for as long as the disease is not getting worse.
Danish: Behandlingen fortsættes, så længe sygdommen ikke forværres.
English: Lynparza received a marketing authorisation valid throughout the EU on 16 December 2014.
Danish: Lynparza fik en markedsføringstilladelse med gyldighed i hele EU den 16. december 2014.
English: Further information on Lynparza can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/lynparza.
Danish: Yderligere information om Lynparza findes på agenturets websted under: ema.europa.eu/medicines/human/EPAR/lynparza.
English: Lynparza is available as tablets (100 and 150 mg) and capsules (50 mg) which the patient takes twice a day.
Danish: Lynparza findes som tabletter (100 og 150 mg) og kapsler (50 mg), som patienten tager to gange dagligt.
English: Lynparza is a cancer medicine used on its own for:
Danish: Lynparza er et kræftlægemiddel, der anvendes alene til:
English: Lynparza contains the active substance olaparib.
Danish: Lynparza indeholder det aktive stof olaparib.
English: Furthermore, while tablets can be taken with food or between meals, the patient should take the capsules at least 1 hour after food and not eat for up to 2 hours afterwards.
Danish: Derudover kan tabletterne tages sammen med mad eller mellem måltider, mens kapslerne bør tages mindst 1 time efter et måltid, hvorefter patienterne ikke bør spise i 2 timer.
English: As for all medicines, data on the use of Lynparza are continuously monitored.
Danish: Som for alle lægemidler bliver data vedrørende brugen af Lynparza løbende overvåget.
English: Other information about Lynparza
Danish: Andre oplysninger om Lynparza
English: Women must not breastfeed during treatment with Lynparza and for a month after stopping treatment.
Danish: Kvinder må ikke amme under behandlingen med Lynparza og i en måned efter behandlingen.
English: The side effects with Lynparza were mostly mild or moderate and were generally manageable.
Danish: Bivirkningerne ved Lynparza var typisk milde eller moderate og var generelt håndterbare.
English: What measures are being taken to ensure the safe and effective use of Lynparza?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Lynparza?
English: The European Medicines Agency therefore decided that Lynparza's benefits are greater than its risks and it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede derfor, at fordelene ved Lynparza opvejer risiciene, og at det kan godkendes til anvendelse i EU.
English: Lynparza can only be obtained with a prescription and treatment should be started and supervised by a doctor experienced in the use of cancer medicines.
Danish: Lynparza fås kun på recept, og behandlingen bør indledes og overvåges af en læge med erfaring i brug af kræftlægemidler.
English: Therefore, when PARP proteins are blocked, the damaged DNA in cancer cells cannot be repaired, and, as a result, the cancer cells die.
Danish: Når PARP-proteinerne således blokeres, kan de ikke reparere det beskadigede dna i kræftcellerne, og derfor dør kræftcellerne.
English: Lynparza can increase the time these patients live without their disease getting worse.
Danish: Lynparza kan forlænge den tid, som disse patienter lever uden sygdomsforværring.
English: The most common side effects with Lynparza (which may affect more than 1 in 10 people) are tiredness, nausea (feeling sick), vomiting, diarrhoea, dyspepsia (heartburn), cough, headache, dysgeusia (taste disturbances), decreased appetite, dizziness, upper abdominal pain (stomach ache), dyspnoea (difficulty breathing), anaemia (low red blood cell counts), leucopenia (low white blood cell counts), neutropenia (low levels of neutrophils, a type of white blood cell that fights infection) and thrombocytopenia (low blood platelet counts).
Danish: De hyppigste bivirkninger ved Lynparza (som kan forekomme hos mere end 1 ud af 10 personer) er træthed, kvalme, opkastning, diarré, halsbrand, hoste, hovedpine, smagsforstyrrelser, nedsat appetit, svimmelhed, mavesmerter, vejrtrækningsbesvær, blodmangel (lavt antal røde blodlegemer), leukopeni (lavt antal hvide blodlegemer), neutropeni (lavt antal af en bestemt type hvide blodlegemer, der bekæmper infektioner) og trombocytopeni (lavt antal blodplader).
English: Side effects reported with Lynparza are carefully evaluated and any necessary action taken to protect patients.
Danish: Bivirkninger rapporteret for Lynparza vurderes omhyggeligt, og der foretages nødvendige forholdsregler for at beskytte patienterne.
English: The dose and the choice between capsules and tablets of Lynparza depends on what disease it is being used for.
Danish: Dosen og valget mellem Lynparza-kapsler og -tabletter afhænger af, hvilken sygdom der skal behandles.
English: In advanced ovarian cancer, the doctor may stop treatment after 2 years if X-rays show no signs of the cancer.
Danish: Ved fremskreden kræft i æggestokkene kan lægen stoppe behandlingen efter 2 år, hvis en røntgenundersøgelse ikke viser tegn på kræft.
English: An overview of Lynparza and why it is authorised in the EU
Danish: En oversigt over Lynparza, og hvorfor det er godkendt i EU